SCHEMBL10650122

SCHEMBL10650122

CN1CCN(Cc2nnc(S)n2Cc2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ LMNA P02545 2/20 0.49
▸ ALDH1A2 O94788 1/20 0.45
▸ ALDH2 P05091 1/20 0.45
▸ ALDH3A1 P30838 1/20 0.45
▸ ALDH1A3 P47895 1/20 0.45
▸ HTR6 P50406 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ GALR3 O60755 1/20 0.42
▸ DRD2 P14416 2/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ FAAH O00519 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ POLB P06746 2/20 0.41
▸ XBP1 P17861 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10671837 0.86 BRD4 (0.46) ALDH1A1ALDH1A2ALDH2ALDH3A1ALDH1A3
SCHEMBL10649474 0.85 ALDH1A1 (0.47) ALDH1A1GAAHTR6SMN1; SMN2DRD2
SCHEMBL10671525 0.83 SMN1; SMN2 (0.47) KDM4EALDH1A1LMNASMN1; SMN2FAAH
SCHEMBL10668329 0.83 BRD4 (0.45) KDM4EALDH1A1GAASMN1; SMN2DRD2
SCHEMBL10648058 0.82 MC4R (0.59) ALDH1A1LMNAL3MBTL1POLBAVPR1A
SCHEMBL30810302 0.82 KDM4E (0.72) KDM4EALDH1A1GAALMNAHTR6
SCHEMBL6928385 0.82 KDM4E (0.72) KDM4EALDH1A1GAALMNAHTR6
SCHEMBL10646620 0.81 SIGMAR1 (0.54) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL10671068 0.80 HRH3 (0.44) ALDH1A1DRD2DRD3KCNH2FAAH
SCHEMBL10647221 0.77 MAP4K4 (0.39) KDM4EALDH1A1LMNASMN1; SMN2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0261804-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1988-03-30 — — EP disclosed
Send feedback